Finance

Pharmaceutical company raises $6 million in financing

Published in Cancer Weekly, September 7th, 2004

Pro-Pharmaceuticals, Inc., (Amex:PRW) announced that it has raised approximately $6 million in gross proceeds from new and existing institutional investors through the private placement of approximately two million newly issued shares of common stock at a price of $3.00 per share.

Investors also will receive 5-year warrants to purchase approximately two million shares of common stock at an exercise price of $4.20. The proceeds from the transaction will be used for general corporate purposes, including clinical trials and research and development. Rodman & Renshaw acted as the placement agent for the transaction.

Pro-Pharmaceuticals, Inc. (Amex:PRW)...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-09-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry